Delivery Order SPE2DR25D3103-SPE2DR26F0A1K
Award Date 1/23/26
Potential Completion Date 2/13/26
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,601.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials, with an ultimate completion date of January 5, 2026. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $16,010.70 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Ryanodex 250 mg vials. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $1,605.44 and an ultimate completion date of October 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $9,632.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ryanodex 250 mg vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ryanodex is a rapid-sequence intubation agent used in emergency...
- The Defense Logistics Agency awarded a $9,632.64 delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials under a firm fixed price contract. The award was announced on September 2, 2025, with an ultimate completion date of September 23, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,606.42 to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials, with performance to be completed by December 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $9,606.42 by the Defense Logistics Agency on January 12, 2026, for the supply of Ryanodex 250 mg vials. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $6,421.76 firm fixed-price delivery order for 250 mg vials of Ryanodex, a muscle relaxant used primarily in anesthesia and critical care settings. This non-competitive delivery order, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $3,210.88 and a completion date of October 3, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to AmerisourceBergen's Corporate Office division, with performance occurring at the company's headquarters in Conshohocken, Pennsylvania. The award is issued under...
- The Defense Logistics Agency awarded a $3,108.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 mg vials of Ryanodex, a pharmaceutical product used in acute care settings. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 10, 2025. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the company's established infrastructure as a major pharmaceutical...